22 Sep 2018 | 3:45 AM
 

Dr. Lal Pathlabs Ltd. Share Price Live (BSE)
0

BSE Code: 539524 | NSE Symbol: LALPATHLAB
939.45
-45.65
(-4.63 %)
21 Sep 2018 | 03:53 PM
Change company
  • Open (Rs)
    970.00
  • Prev. close (Rs.)
    985.10
  • High (Rs.)
    973.75
  • Low (Rs.)
    926.00
  • 52W H (Rs.)
    1,120.00
  • 52W L (Rs.)
    717.65
  • Volume
    11579
  • MCap (Rs in Cr.)
    7,828.72
0
0.00
(0.00 %)
  • Open (Rs)
    0.00
  • High (Rs)
    0.00
  • Low (Rs)
    0.00
  • Prev. close(Rs)
    0.00
  • Contracts Tra.
  • Turnover (Cr.)
    N.A.
  • Open Interest
  • Open Int. chg
    0.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
20.49
Operating Margin (%)
24.97
Gross Profit Margin (%)
21.84
Net Profit Margin (%)
16.15
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
18.50
Earning Retention Ratio
81.61

News

10 Jul 2018 - 11:35:00-Shares of Dr...
15 May 2018 - 11:35:00-Shares of Dr...
14 May 2018 - 17:16:00-The company reported standalone net profit of Rs 39...
08 Feb 2018 - 19:26:00-The company reported standalone net profit of Rs 35...

Announcements

18-Sep-2018
Dr. Lal Pathlabs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates
17-Sep-2018
Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
17-Sep-2018
Dr. Lal Pathlabs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates
12-Sep-2018
Dr. Lal Pathlabs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12-Sep-2018
Dr. Lal Pathlabs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates

Religare Research

21 Sep 2018 | 10:57 AM
Here’s an opportunity to earn steady returns through the capital market. If you are seeking a predic...
21 Sep 2018 | 10:31 AM
• Gold rises on weaker dollar, heads for 1st weekly gain in four • Crude Oil prices pull back as Tru...
21 Sep 2018 | 10:12 AM
The rupee ended at 72.37 to a dollar in Mumbai, against a record-low close of 72.98. The session mar...
21 Sep 2018 | 09:58 AM
Highlights: Agri markets look for recovery in prices at these lower levels as rising export demand...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

       
Promotors57.42%
Mutual Funds/UTI10.11%
FI/Banks1.57%
Insurance1.57%
FII13.28%
Government0.00%
Others11.32%

Peer Group

Company Intraday Graph
 Merck Ltd.
2,875.15(-2.94)
3302
 AstraZeneca Pharma India Ltd.
1,722.25(0.48)
3274
 Ajanta Pharma Ltd.
1,113.00(-5.54)
3790
 Ipca Laboratories Ltd.
709.55(-5.46)
3488

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Dr. Lal Pathlabs Ltd.-100.4050.8561.90
NIFTY(S&P CNX)-427.80402.00987.85
BSE SENSEX-1,444.151,409.213,705.42
BSE 500-694.29291.23764.68

Corporate Details

Key Personal
Arvind Lal
Chairman & Managing Director
Naveen Wadhera
Non Exe. & Nominee Director
Om Prakash Manchanda
WholeTime Director & CEO
Key Address
Registered Office
Block E Sector 18 Rohini,New Delhi,Delhi

Tel:011-30244199, Fax:011-27882134

cs@lalpathlabs.com
https://www.lalpathlabs.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C 101 247 Park ? L.B.S. Marg Vikhroli (West)